ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the common malignant tumors. The prognosis and five-year survival rate of HCC are not promising due to tumor recurrence and metastasis. Exploring markers that contribute to the early diagnosis of HCC, markers for prognostic evaluation of HCC patients, and eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fahui, Liang, Jiadong, Long, Puze, Zhu, Lilan, Hou, Wanyun, Wu, Xueming, Luo, Chunying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770814/
https://www.ncbi.nlm.nih.gov/pubmed/35071004
http://dx.doi.org/10.3389/fonc.2021.799566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770814/
https://www.ncbi.nlm.nih.gov/pubmed/35071004
http://dx.doi.org/10.3389/fonc.2021.799566

Ejemplares similares